dipropylene glycol n-butyl ether

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: dipropylene glycol n-butyl ether
• 英文别名: DOWANOL DPnB；n-Butylmonoether v. Dipropylenglycol；2-(2-butoxy-propoxy)-propan-1-ol；2-(2-Butoxypropoxy)propan-1-ol
• 化学式: C₁₀H₂₂O₃
• mdl: MFCD00272582
• 分子量: 190.283
• InChiKey: WMDZKDKPYCNCDZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  13
• 可旋转键数：
  8
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  38.7
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  己二酸 、 dipropylene glycol n-butyl ether 在 磷酸 作用下， 177.0~190.0 ℃ 、73.0 kPa 条件下， 反应 12.5h， 生成 bis-dipropylene glycol n-butyl ether adipate
  参考文献：
  名称：

  [EN] PROCESS FOR PRODUCING LOW VOC COALESCING AIDS
  [FR] PROCÉDÉ DE PRODUCTION D'AGENTS DE COALESCENCE À FAIBLE TENEUR EN COV

  摘要：

  一种包括在磷酸存在下，将单羧酸或二羧酸及/或酸酐与乙二醇醚反应以生产具有低色度和低VOC含量的乙二醇醚酯产品的过程。

  公开号：

  WO2015200088A1

文献信息

• [EN] PHOTOCHROMIC AND ELECTROCHROMIC DIARYLETHENE COMPOUNDS WITH IMPROVED PHOTOSTABILITY AND SOLUBILITY<br/>[FR] COMPOSÉS DIARYLÉTHÈNE PHOTOCHROMIQUES ET ÉLECTROCHROMES PRÉSENTANT UNE PHOTOSTABILITÉ ET UNE SOLUBILITÉ AMÉLIORÉES
  申请人：SWITCH MAT INC

  公开号：WO2020198868A1

  公开（公告）日：2020-10-08

  A diarylethene compound reversibly convertible under photochromic and electrochromic conditions between a ring-open isomer of Formula (1A) and a ring-closed isomer of Formula (IB) wherein R5 is a substituted phenyl ring and Re is a substituted thiophene ring is provided. The photochromic-electrochromic diarylethene compound of Formula (1A)/(1B) have improved photochromic, electrochromic or photochromic and electrochromic properties, and is useful to provide variation of the light transmission properties of optical filters. The compound also possesses improved solubility making it suitable for incorporation in commercial products..

  一种二芳基乙烯化合物，在光致色变和电致色变条件下，在式（1A）的环开异构体和式（1B）的环闭异构体之间可逆转换，其中R5是取代苯环，Re是取代噻吩环。式（1A）/（1B）的光致-电致色变二芳基乙烯化合物具有改进的光致、电致或光致和电致性能，并可用于改变光学滤光片的透光性能。该化合物还具有改进的溶解性，适合用于商业产品中。
• Method for manufacturing pigment dispersed liquid, and pigment dispersed liquid, and ink for ink-jet printer recording using said pigment dispersed liquid
  申请人：SEIKO EPSON CORPORATION

  公开号：US20020088375A1

  公开（公告）日：2002-07-11

  A method for manufacturing a pigment dispersed liquid, comprising at least: Step A of introducing a hydrophilic dispersibility-imparting group directly and/or via another atomic group to the surface of pigment particles; Step B of dispersing the pigment obtained in Step A in an aqueous medium; and Step C of conducting refining treatment of the dispersed liquid obtained in Step B.

  制造颜料分散液的方法，至少包括： 步骤A：将亲水性分散性赋予基团直接和/或通过另一个原子基团引入颜料颗粒的表面； 步骤B：将步骤A中获得的颜料分散在水性介质中； 步骤C：对步骤B中获得的分散液进行精炼处理。
• Method of Fabricating Glycol Monoalkyl Ether Acetate Using Acidic Ionic Liquid Catalyst
  申请人：Wu Jung-Chung

  公开号：US20110184207A1

  公开（公告）日：2011-07-28

  A new method for fabricating glycol monoalkyl ether acetate (GMAEA) is provided. A Bronsted acidic ionic liquid is used. After some reactions, two layers of materials are formed. A product of GMAEA is obtained at the upper layer. The lower layer is the ionic liquid. Thus, the ionic liquid is reusable for re-fabricating the product. And, furthermore, waste acid is reduced.

  提供了一种制备甘醇单烷基醚醋酸酯（GMAEA）的新方法。使用了一种Brønsted酸性离子液体。经过一些反应，形成了两层材料。在上层获得了GMAEA的产物。下层是离子液体。因此，离子液体可用于再次制备产品。此外，废酸也得到了减少。
• ANTHELMINTIC COMPOUNDS AND COMPOSITIONS AND METHOD OF USING THEREOF
  申请人：Meng Charles Q.

  公开号：US20140142114A1

  公开（公告）日：2014-05-22

  The present invention relates to novel anthelmintic compounds of formula (I) below: wherein Y and Z are independently a bicyclic carbocyclic or a bicyclic heterocyclic group, or one of Y or Z is a bicyclic carbocyclic or a bicyclic heterocyclic group and the other of Y or Z is alkyl, alkenyl, alkynyl, cycloalkyl, phenyl, heterocyclyl or heteroaryl, and variables X 1 , X 2 , X 3 , X 4 , X 5 , X 6 , X 7 and X 8 are as defined herein. The invention also provides for veterinary compositions comprising the anthelmintic compounds of the invention, and their uses for the treatment and prevention of parasitic infections in animals.

  本发明涉及以下式（I）的新型驱虫化合物： 其中 Y和Z分别是双环碳环或双环杂环基团，或者Y或Z中的一个是双环碳环或双环杂环基团，另一个是烷基，烯基，炔基，环烷基，苯基，杂环基或杂芳基，以及变量X 1 ，X 2 ，X 3 ，X 4 ，X 5 ，X 6 ，X 7 和X 8 如本文所定义。本发明还提供了包含本发明的驱虫化合物的兽药组合物，以及它们用于治疗和预防动物寄生虫感染的用途。
• [EN] CHEMICAL COMPOUNDS<br/>[FR] COMPOSÉS CHIMIQUES
  申请人：AVISTA PHARMA SOLUTIONS INC

  公开号：WO2020160075A1

  公开（公告）日：2020-08-06

  The present disclosure describes novel compounds, or their pharmaceutically acceptable salts, pharmaceutical compositions containing them, and their medical uses. The compounds of the disclosure have activity as prostaglandin EP4 receptor antagonists, and are useful in the treatment or alleviation of pain and inflammation and other inflammation-associated disorders, such as arthritis, treating or preventing disorders or medical conditions selected from pain, inflammatory diseases and the like. Also described herein are methods of treating pain by administering the compounds of the disclosure, which are EP4 receptor antagonists.

  本公开描述了新颖化合物或其药用盐、含有它们的药物组合物以及它们的医药用途。本公开的化合物具有前列腺素EP4受体拮抗剂的活性，并且在治疗或缓解疼痛和炎症以及其他与炎症相关的疾病，如关节炎，治疗或预防疼痛、炎症性疾病等疾病或医疗状况方面具有用处。本文还描述了通过给予本公开的化合物（即EP4受体拮抗剂）来治疗疼痛的方法。